SCHEMBL5490658

SCHEMBL5490658

C=CS(=O)(=O)C(=O)[C@@H](N)CC(C)C

nearest known ligand 0.48

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SLC7A5 Q01650 1/20 0.48
ANPEP P15144 6/20 0.41
RNPEP Q9H4A4 2/20 0.41
DNPEP Q9ULA0 2/20 0.41
SLC1A3 P43003 3/20 0.38
SLC1A2 P43004 3/20 0.38
LARS1 Q9P2J5 3/20 0.38
LAP3 P28838 2/20 0.33
ERAP1 Q9NZ08 1/20 0.33
GRIK1 P39086 2/20 0.32
GRIK2 Q13002 2/20 0.32
SLC1A1 P43005 2/20 0.32
TSHR P16473 2/20 0.32
ALDH1A1 P00352 1/20 0.32
MAPK1 P28482 1/20 0.32
KDM4E B2RXH2 1/20 0.31
POLB P06746 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8368378 1.00 SLC7A5 (0.48) SLC7A5ANPEPRNPEPDNPEPSLC1A3
SCHEMBL4970513 0.82 LARS1 (0.40) LARS1ALDH1A1MAPK1KDM4E
SCHEMBL8368976 0.80 LARS1 (0.38) SLC7A5ANPEPRNPEPDNPEPLARS1
SCHEMBL4972626 0.80 LARS1 (0.38) SLC7A5ANPEPRNPEPDNPEPLARS1
Leucine SCHEMBL6685428 0.77 SLC7A5 (0.67) SLC7A5SLC1A3SLC1A2LARS1GRIK1
Leucine SCHEMBL6685434 0.77 SLC7A5 (0.67) SLC7A5SLC1A3SLC1A2LARS1GRIK1
SCHEMBL1001398 0.76 CA12 (0.31)
SCHEMBL8365781 0.74 RNPEP (0.35) ANPEPRNPEP
SCHEMBL8365782 0.74 RNPEP (0.35) ANPEPRNPEP
SCHEMBL30018651 0.74 SLC7A5 (0.56) SLC7A5ANPEPRNPEPDNPEPSLC1A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0912601-A1 SUPPRESSION OF IMMUNE RESPONSE VIA INHIBITION OF CATHEPSIN S MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 1999-05-06 EP claimed
WO-1997040066-A1 SUPPRESSION OF IMMUNE RESPONSE VIA INHIBITION OF CATHEPSIN S MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 1997-10-30 WO claimed
US-7238659-B2 Reducing axon degeneration with proteasome inhibitors CHILDREN'S MEDICAL CENTER CORPORATION (US) 2007-07-03 US disclosed
US-20060074028-A1 Reducing axon degeneration with proteasome inhibitors CHILDREN'S MEDICAL CENTER CORP 2006-04-06 US disclosed
US-7012063-B2 Reducing axon degeneration with proteasome inhibitors CHILDREN'S MEDICAL CENTER CORPORATION (US) 2006-03-14 US disclosed
WO-1999058153-A1 METHODS OF DIAGNOSING AND MODULATING AUTOIMMUNITY BRIGHAM & WOMEN'S HOSPITAL (US) 1999-11-18 WO disclosed